International HPV Awareness Day

Headshot of Nicole Campos.

CHDS faculty Nicole Campos traveled to Brasília, Brazil to mark International HPV Awareness Day on March 4. Campos joined researchers from Fundação Oswaldo Cruz (Fiocruz), the Brazilian Ministry of Health, and the Brazilian National Cancer Institute (INCA) for a symposium on cervical cancer prevention.

Campos’s lecture, entitled “Striving for Equity and Efficiency of Cervical Screening: The Human Papillomavirus-Automated Visual Evaluation (PAVE) Validation Study” described the consortial study led by the U.S. National Cancer Institute to evaluate a novel cervical screening and triage strategy for resource-limited settings as part of a global strategy to reduce cervical cancer burden. To date, more than 25,000 women in 9 countries have been screened as part of the HPV-automated visual evaluation (PAVE) study. The study integrates self-sampled HPV testing, deep-learning-based automated visual evaluation (AVE), and targeted therapies, aiming to validate a protocol that combines innovative biomarkers for accurate, feasible, and cost-effective cervical cancer prevention in resource-limited areas. This approach holds promise for cervical cancer prevention implementation efforts worldwide.

Campos’ research revolves around health decision science, epidemiology, and implementation science. Through decision-analytic and mathematical modeling techniques, she assesses the comparative and cost-effectiveness of cervical cancer prevention methods in low- and middle-income countries (LMICs). Additionally, she explores optimal cervical cancer screening approaches for HIV-infected women and evaluates the initiation of new cervical cancer screening initiatives.

Learn more: Read about International HPV Awareness Day
Learn more: Read the publication, Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy
Learn more: Read the publication, Moving Towards a Strategy to Accelerate Cervical Cancer Elimination in a High-Burden City—Lessons Learned from the Amazon City of Manaus, Brazil

Related news: Achieving the Cancer Moonshot Goal
Related news: CHDS at International HPV Meeting